Urgent Eye Drop Recall Hits 3.1 Million Bottles at Major Retailers
More than 3. 1 million bottles of eye drop products are being recalled after federal health officials raised sterility concerns. The recall involves products sold under several brand names at major retailers, including Walgreens, CVS, Harris Teeter and Publix. The Food and Drug Administration says consumers should stop using the affected bottles immediately.
What is being recalled
K. C. Pharmaceuticals, Inc. is recalling 3, 111, 072 bottles of over-the-counter eye drop products because of a lack of assurance of sterility. The affected items were sold under brand names including Artificial Tears, Dry Eye Relief Eye Drops, Ultra Lubricating Eye Drops and Soothing Tears.
The Food and Drug Administration has said the use of these products may cause temporary or medically reversible health effects. The action has been classified as a Class II recall, which the agency uses for products that can cause temporary or medically reversible health problems.
The recall covers eye drop bottles sold at major retailers, including Walgreens and CVS, with other affected stores identified in the recall notice as Harris Teeter and Publix. The products are tied to K. C. Pharmaceuticals, Inc., based in Pomona, California.
Immediate reaction from federal health officials
Federal health officials are urging consumers to stop using the affected bottles immediately. The Food and Drug Administration said the products may create temporary or medically reversible health effects, but there are not yet reports of injuries associated with the eye drops.
The recall began in early March, and the reason behind the action remains unclear. K. C. Pharmaceuticals, Inc. did not immediately respond to a request for comment.
What consumers need to know now
Consumers are being directed to check bottle labels and lot information for the recalled products. The affected brands include several eye drop products sold through national retail chains, and the recall is focused on sterility concerns rather than reported injuries.
The FDA’s classification means the issue is serious enough to warrant prompt action, even though the expected health effects are described as temporary or medically reversible. That makes the eye drop recall especially important for anyone who has recently bought over-the-counter eye care products from the listed retailers.
What comes next
More details may emerge as retailers and the manufacturer move through the recall process and consumers check their purchases against the affected lots. For now, the clearest guidance is simple: stop using the recalled eye drop bottles immediately and watch for further instructions tied to the recall. The eye drop recall is now one of the largest over-the-counter eye care actions flagged in this set of federal warnings.
